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Abstract——The family of voltage-gated sodium
channels initiates action potentials in all types of ex-
citable cells. Nine members of the voltage-gated so-
dium channel family have been characterized in mam-
mals, and a 10th member has been recognized as a
related protein. These distinct sodium channels have
similar structural and functional properties, but they
initiate action potentials in different cell types and
have distinct regulatory and pharmacological proper-
ties. This article presents the molecular relationships
and physiological roles of these sodium channel pro-
teins and provides comprehensive information on
their molecular, genetic, physiological, and pharmaco-
logical properties.
Introduction
Voltage-gated sodium channels are responsible for ac-
tion potential initiation and propagation in excitable
cells, including nerve, muscle, and neuroendocrine cell
types. They are also expressed at low levels in nonexcit-
able cells, where their physiological role is unclear. So-
dium channels are the founding members of the ion
channel superfamily in terms of their discovery as a
protein and determination of their amino acid sequence.
This article presents an introduction to their biochemi-
cal, molecular, and genetic properties, physiological
roles, and pharmacological significance.
Sodium Channel Subunits
Sodium channels consist of a highly processed  sub-
unit, which is approximately 260 kDa, associated with
auxiliary  subunits (Catterall, 2000). Sodium channels
in the adult central nervous system and heart contain 1
through 4 subunits, whereas sodium channels in adult
skeletal muscle have only the 1 subunit (Isom, 2001).
The pore-forming  subunit is sufficient for functional
expression, but the kinetics and voltage dependence of
channel gating are modified by the  subunits, and these
auxiliary subunits are involved in channel localization
and interaction with cell adhesion molecules, extracel-
lular matrix, and intracellular cytoskeleton. The  sub-
units are organized in four homologous domains (I–IV),
each of which contain six transmembrane  helices (S1–
S6) and an additional pore loop located between the S5
and S6 segments (Fig. 1). The pore loops line the outer,
narrow entry to the pore, whereas the S5 and S6 seg-
ments line the inner, wider exit from the pore. The S4
segments in each domain contain positively charged
amino acid residues at every third position. These resi-
dues serve as gating charges and move across the mem-
brane to initiate channel activation in response to depo-
larization of the membrane. The short intracellular loop
connecting homologous domains III and IV serves as the
inactivation gate, folding into the channel structure and
blocking the pore from the inside during sustained de-
polarization of the membrane.
Sodium Channel Classification and
Nomenclature
A variety of different sodium channels has been iden-
tified by electrophysiological recording, biochemical pu-
rification, and cloning (Goldin, 2001). The sodium chan-
nels are members of the superfamily of ion channels that
includes voltage-gated potassium and calcium channels
(Yu and Catterall, 2004); however, unlike the different
classes of potassium and calcium channels, the func-
tional properties of the known sodium channels are rel-
atively similar. Despite their similarity of function, the
sodium channels were originally named in many differ-
ent ways, with no consistent nomenclature for the vari-
ous isoforms. To eliminate confusion resulting from the
multiplicity of names, a standardized nomenclature was
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developed for voltage-gated sodium channels (Goldin et
al., 2000). This nomenclature is based on that for volt-
age-gated potassium channels (Chandy and Gutman,
1993). It uses a numerical system to define subfamilies
and subtypes based on similarities between the amino
acid sequences of the channels. A comparable nomencla-
ture has also been adopted for voltage-gated calcium
channels (Ertel et al., 2000; Catterall et al., 2005). In
this nomenclature system, the name of an individual
channel consists of the chemical symbol of the principal
permeating ion (Na) with the principal physiological
regulator (voltage) indicated as a subscript (NaV). The
number following the subscript indicates the gene sub-
family (currently only NaV1), and the number following
the full point identifies the specific channel isoform (e.g.,
NaV1.1). This last number has been assigned according to
the approximate order in which each gene was identified.
Splice variants of each family member are identified by
lowercase letters following the numbers (e.g., NaV1.1a).
The nine mammalian sodium channel isoforms that
have been identified and functionally expressed are all
greater than 50% identical in amino acid sequence in the
transmembrane and extracellular domains, where the
amino acid sequence is similar enough for clear alignment
(Fig. 2A). For potassium channels and calcium channels,
all members of distinct subfamilies are less than 50% iden-
tical to those of other families, and there is much closer
sequence similarity within families (Chandy and Gutman,
1993; Ertel et al., 2000). The sodium channel sequences
vary more continuously, without defining separate fami-
lies. By this criterion, all of the nine sodium channel iso-
forms may be considered members of one family.
Sodium Channel Genes
To test this hypothesis more critically, the nine so-
dium channel amino acid sequences were aligned and
compared for relatedness using a maximum parsimony
procedure that measured their evolutionary distance by
calculating the number of nucleotide changes required
for the change in codon at each position (Fig. 2B). The
resulting phylogenetic tree is consistent with designa-
tion of these sodium channels as a single family. NaV1.1,
NaV1.2, NaV1.3, and NaV1.7 are the most closely related
group by this analysis. All four of these sodium channels
are highly tetrodotoxin-sensitive and are broadly ex-
pressed in neurones. Their genes are all located on hu-
man chromosome 2q23-24, consistent with a common
evolutionary origin. NaV1.5, NaV1.8, and NaV1.9 are
also closely related (Fig. 2B), and their amino acid se-
quences are greater than 64% identical to those of the
four sodium channels encoded on chromosome 2. These
sodium channels are tetrodotoxin-resistant to varying
degrees due to changes in amino acid sequence at a
FIG. 1. Transmembrane organization of sodium channel subunits. The primary structures of the subunits of the voltage-gated ion channels are
illustrated as transmembrane-folding diagrams. Cylinders represent probable -helical segments. Bold lines represent the polypeptide chains of each
subunit, with length approximately proportional to the number of amino acid residues in the brain sodium channel subtypes. The extracellular
domains of the 1 and 2 subunits are shown as immunoglobulin-like folds., sites of probable N-linked glycosylation; P, sites of demonstrated protein
phosphorylation by protein kinase A (circles) and protein kinase C (diamonds); shaded, pore-lining S5-P-S6 segments; white circles, the outer (EEDD)
and inner (DEKA) rings of amino residues that form the ion selectivity filter and tetrodotoxin binding site; , S4 voltage sensors; h in shaded circle,
inactivation particle in the inactivation gate loop; open shaded circles, sites implicated in forming the inactivation gate receptor. Sites of binding of
- and -scorpion toxins and a site of interaction between  and 1 subunits are also shown.
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single position in domain I, and they are highly ex-
pressed in heart and dorsal root ganglion neurons (Foz-
zard and Hanck, 1996; Catterall, 2000). Their genes are
located on human chromosome 3p21-24, consistent with
a common evolutionary origin. The isoforms NaV1.4,
expressed primarily in skeletal muscle, and NaV1.6, ex-
pressed primarily in the central nervous system, are set
apart from these other two closely related groups of
sodium channel genes (Fig. 2B). Although their amino
acid sequences are greater than 84% identical to the
group of sodium channels whose genes are located on
chromosome 2 (Fig. 2A), their phylogenetic relationship
is much more distant when analyzed by parsimony com-
parison (Fig. 2B). This distant evolutionary relationship
is consistent with the location of the genes encoding
these two sodium channels on chromosomes 17q23-25
and 12q13, respectively. The chromosome segments car-
rying the sodium channel genes are paralogous seg-
ments that contain many sets of related genes, including
the homeobox gene clusters. These segments were gen-
erated by whole genome duplication events during early
vertebrate evolution (Plummer and Meisler, 1999). The
comparisons of amino acid sequence identity and phylo-
genetic and chromosomal relationships lead to the con-
clusion that all nine members of the sodium channel
family that have been functionally expressed are mem-
bers of a single family of proteins and have arisen from
gene duplications and chromosomal rearrangements rela-
tively recently in evolution. These results contrast with
those for potassium channels and calcium channels, for
which distinct gene families have arisen earlier in evolu-
tion and have been maintained as separate families to the
present (Chandy and Gutman, 1993; Ertel et al., 2000).
In addition to these nine sodium channels that have
been functionally expressed, closely related sodium
channel-like proteins have been cloned from mouse, rat,
and human but have not yet been functionally expressed
(Nax). They are approximately 50% identical to the NaV1
subfamily of channels but more than 80% identical to
each other. They have significant amino acid sequence
differences in the voltage sensors, inactivation gate, and
pore region that are critical for channel function and
have previously been proposed as a distinct subfamily
(George et al., 1992). These atypical sodium channel-like
proteins are expressed in heart, uterus, smooth muscle,
astrocytes, and neurones in the hypothalamus and pe-
ripheral nervous system. Because of their sequence dif-
ferences, it is possible that these channels are not highly
sodium-selective or voltage-gated. Although these pro-
teins have striking differences in amino acid sequence in
highly conserved regions of sodium channels, their
amino acid sequence is greater than 50% identical to
other sodium channels. They are closely related phylo-
genetically to the group of sodium channels on human
chromosome 2q23-24, where their gene is also located
(Goldin et al., 2000). Successful functional expression of
these atypical sodium channel-like proteins and identi-
fication of additionally related sodium channels may
provide evidence for a second sodium channel subfamily.
Four auxiliary subunits of sodium channels have been
defined thus far: NaV1, NaV2, NaV3, and NaV4 (Cat-
FIG. 2. Amino acid sequence similarity and phylogenetic relationships
of voltage-gated sodium channel  subunits. Phylogenetic relationships
by maximum parsimony analysis of rat sodium channel sequences
Nav1.1–Nav1.9 and Nax. To perform the analysis, the amino acid se-
quences for all isoforms were aligned using Clustal W. The amino acid
sequences in the alignments were then replaced with the published
nucleotide sequences, and the nucleotide sequence alignments were sub-
jected to analysis using the program PAUP*. Divergent portions of the
terminal regions and the cytoplasmic loops between domains I–II and
II–III were excluded from the PAUP* analysis. The tree was rooted by
including the invertebrate sodium channel sequences during the gener-
ation of the tree, although these sequences are not shown in the figure.
TABLE 1
Receptor sites on sodium channels
Receptor Site Toxin or Drug Domains
Neurotoxin receptor Tetrodotoxin IS2–S6, IIS2–S6
site 1 Saxitoxin IIIS2–S6, IVS2–S6
-Conotoxin
Neurotoxin receptor Veratridine IS6, IVS6
site 2 Batrachotoxin
Grayanotoxin
Neurotoxin receptor -Scorpion toxins IS5–IS6, IVS3–S4
site 3 Sea anemone toxins IVS5–S6
Neurotoxin receptor
site 4
-Scorpion toxins IIS1–S2, IIS3–S4
Neurotoxin receptor Brevetoxins IS6, IVS5
site 5 Ciguatoxins
Neurotoxin receptor
site 6
-Conotoxins IVS3–S4
Local anesthetic Local anesthetic drugs IS6, IIIS6, IVS6
receptor site Antiarrhythmic drugs
Antiepileptic drugs
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terall, 2000; Isom, 2001; Yu et al., 2004). In the event that
additional subunits are identified, we propose that the
nomenclature should be comparable to that for the auxil-
iary subunits of calcium channels (Ertel et al., 2000).
Sodium Channel Molecular Pharmacology
All of the pharmacological agents that act on sodium
channels have receptor sites on the  subunits. At least
six distinct receptor sites for neurotoxins and one recep-
tor site for local anesthetics and related drugs have been
identified (Ceste`le and Catterall, 2000; Table 1). Neuro-
toxin receptor site 1 binds the nonpeptide pore blockers
tetrodotoxin and saxitoxin and the peptide pore blocker
-conotoxin (Fozzard and Hanck, 1996; Terlau and
Stu¨hmer, 1998; Catterall, 2000). The receptor sites for
these toxins are formed by amino acid residues in the
pore loops and immediately on the extracellular side of
the pore loops at the outer end of the pore. Neurotoxin
receptor site 2 binds a family of lipid-soluble toxins,
including batrachotoxin, veratridine, aconitine, and
grayanotoxin, which enhance activation of sodium chan-
nels. Photoaffinity labeling and mutagenesis studies im-
plicate transmembrane segments IS6 and IVS6 in the
receptor site for batrachotoxin (Ceste`le and Catterall,
2000). Neurotoxin receptor site 3 binds the -scorpion
toxins and sea anemone toxins, which slow the coupling
of sodium channel activation to inactivation. These pep-
tide toxins bind to a complex receptor site that includes
the S3-S4 loop at the outer end of the S4 segment in
domain IV (Ceste`le and Catterall, 2000). Neurotoxin
receptor site 4 binds the -scorpion toxins, which en-
hance activation of the channels. The receptor site for
the -scorpion toxins includes the S3-S4 loop at the
extracellular end of the voltage-sensing S4 segments in
domain II (Ceste`le and Catterall, 2000). Neurotoxin re-
ceptor site 5 binds the complex polyether toxins breve-
toxin and ciguatoxin, which are made by dinoflagellates
and cause toxic red tides in warm ocean waters (Ceste`le
and Catterall, 2000). Transmembrane segments IS6 and
IVS5 are implicated in brevetoxin binding from photoaf-
finity labeling studies (Ceste`le and Catterall, 2000).
Neurotoxin receptor site 6 binds -conotoxins, which
slow the rate of inactivation like the -scorpion toxins.
The location of neurotoxin receptor site 6 is unknown.
Finally, the local anesthetics and related antiepileptic
and antiarrhythmic drugs bind to overlapping receptor
sites located in the inner cavity of the pore of the sodium
channel (Catterall, 2000). Amino acid residues in the S6
segments from at least three of the four domains con-
tribute to this complex drug receptor site, with the IVS6
segment playing the dominant role.
Tables 2 through 10 summarize the major molecular,
physiological, and pharmacological properties for each of
the nine sodium channels that have been functionally
expressed. Quantitative data are included for voltage
dependence of activation and inactivation, single-chan-
nel conductance, and binding of drugs and neurotoxins,
focusing on those agents that are widely used and diag-
nostic of channel identity and function.
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TABLE 2
NaV1.1 channels
Channel name NaV1.1
Description Voltage-gated sodium channel  subunit
Other names Brain type I, rat 1, R-I
Molecular information Human: 2009aa, P35498, X65362, chr. 2q24.3, SCN1A
Rat: 2009aa, P04775 NM_03975, chr. 3q21
Mouse: 2048aa, Q68V28, XM_61957, chr. 2
Associated subunits 1, 2, 3, 4
Functional assays Voltage-clamp, neurotoxin-activated ion flux, voltage-sensitive dyes
Current INa
Conductance Not established
Ion selectivity Na  K  Ca2
Activation Va  33 mV
1
Inactivation Vh  72 mV, th  0.7 ms at 10 mV
1
Activators Veratridine, batrachotoxin, aconitine, grayanotoxin, and related natural organic toxins; -scorpion
toxins
Gating modifiers -Scorpion toxins, sea anemone toxins, and -conotoxins, which all slow inactivation
Blockers Tetrodotoxin (EC50  6 nM)
1, saxitoxin; local anesthetic, antiepileptic, and antiarrhythmic drugs
Radioligands 3Hsaxitoxin, 3Hbatrachotoxin, 125Iscorpion toxins
Channel distribution Central neurons: primarily localized to cell bodies2; cardiac myocytes3
Physiological functions Action potential initiation and repetitive firing in neurons; excitation-contraction coupling in cardiac
myocytes
Mutations and pathophysiology Point mutations and deletions cause inherited febrile seizures, GEFS, and severe myoclonic
epilepsy of infancy4–6
Pharmacological significance Site of action of antiepileptic drugs; potential site of side effects of local anesthetics that enter the
general circulation or cerebrospinal fluid
aa, amino acids; chr., chromosome; GEFS, generalized epilepsy with febrile seizures plus.
1. Clare JJ, Tate SN, Nobbs M, and Romanos MA (2000) Voltage-gated sodium channels as therapeutic targets. Drug Discov Today 5:506–520.
2. Westenbroek RE, Merrick DK, and Catterall WA (1989) Differential subcellular localization of the RI and RII Na
 channel subtypes in central neurons. Neuron
3:695–704.
3. Maier SK, Westenbroek RE, Schenkman KA, Feigl EO, Scheuer T, and Catterall WA (2002) An unexpected role for brain-type sodium channels in coupling of cell surface
depolarization to contraction in the heart. Proc Natl Acad Sci USA 99:4073–4078.
4. Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G, An-Gourfinkel I, Brice A, LeGuern E, Moulard B, Chaigne D, et al. (2000) Mutations ofSCN1A, encoding
a neuronal sodium channel, in two families with GEFS  2. Nat Genet 24:343–345.
5. Spampanato J, Escayg A, Meisler MH, and Goldin AL (2001) Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with
febrile seizures plus type 2. J Neurosci 21:7481–7490.
6. Nabbout R, Gennaro E, Dalla Bernardina B, Dulac O, Madia F, Bertini E, Capovilla G, Chiron C, Cristofori G, Elia M, et al. (2003) Spectrum of SCN1A mutations in
severe myoclonic epilepsy of infancy. Neurology 60:1961–1967.
NOMENCLATURE AND RELATIONSHIPS OF VOLTAGE-GATED SODIUM CHANNELS 401
TABLE 3
NaV1.2 channels
Channel name NaV1.2
Description Voltage-gated sodium channel  subunit
Other names Brain type II, rat II, R-II
Molecular information Human: 2005aa, Q99250, X65361, M94055, NM_021007, chr. 2q22-23, SCN2A
Rat: 2006aa, P04775, X03630, X61149, NM_012647, 3q24
Mouse: Q68V27, fragment only, chr. 2
Associated subunits 1, 2, 3, 4
Functional assays Voltage-clamp, neurotoxin-activated ion flux, voltage-sensitive dyes
Current INa
Conductance Not established
Ion selectivity Na  K  Ca2
Activation Va  24 mV, a  0.4 ms at Va
1,2 (see “Comments”)
Inactivation Vh  53 mV, h  8 ms at Va, th  0.8 ms at 0 mV
1,2
Activators Veratridine, batrachotoxin, aconitine, grayanotoxin, and related organic toxins; -scorpion toxins
Gating modifiers -Scorpion toxins, sea anemone toxins, and -conotoxins, which all slow inactivation
Blockers Tetrodotoxin (EC50  12 nM),
3 saxitoxin; local anesthetic, antiepileptic, and antiarrhythmic drugs
(EC50  11 mM for lidocaine in inactivated state)
Radioligands 3Hsaxitoxin (Kd  1 nM),
5 3Hbatrachotoxin, 125I-scorpion toxin (Kd  2 nM),
6 125I-scorpion
toxin (Kd  0.2 nM)
7
Channel distribution Central neurones: primarily localized to unmyelinated and premyelinated axons8–10
Physiological functions Action potential initiation and conduction, repetitive firing
Mutations and pathophysiology A point mutation has been reported to cause inherited febrile seizures and epilepsy11
Pharmacological significance Site of action of antiepileptic drugs; probable site of side effects of local anesthetics that reach the
general circulation or the cerebrospinal fluid
Comments Values given for activation and inactivation parameters are for  subunits expressed alone in
mammalian cells and measured with an intracellular solution containing aspartate or chloride2 as
the primary anion; coexpression of different  subunits gives positive or negative shifts in voltage
dependence
aa, amino acids; chr., chromosome.
1. Mantegazza M, Yu FH, Catterall WA, and Scheuer T (2001) Role of the C-terminal domain in inactivation of brain and cardiac sodium channels. Proc Natl Acad Sci
USA 98:15348–15353.
2. Qu Y, Curtis R, Lawson D, Gilbride K, Ge P, DeStefano PS, Silos-Santiago I, Catterall WA, and Scheuer T (2001) Differential modulation of sodium channel gating and
persistent sodium currents by the 1, 2, and 3 subunits. Mol Cell Neurosci 18:570–580.
3. Noda M, Ikeda T, Kayano T, Suzuki H, Takeshima H, Kurasaki M, Takahashi H, and Numa S (1986) Existence of distinct sodium channel messenger RNAs in rat brain.
Nature 320:188–192.
4. Ragsdale DR, McPhee JC, Scheuer T, and Catterall WA (1996) Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of
voltage-gated Na channels. Proc Natl Acad Sci USA 93:9270–9275.
5. West JW, Scheuer T, Maechler L, and Catterall WA (1992) Efficient expression of rat brain type IIA Na channel  subunits in a somatic cell line. Neuron 8:59–70.
6. Rogers JC, Qu Y, Tanada TN, Scheuer T, and Catterall WA (1996) Molecular determinants of high affinity binding of -scorpion toxin and sea anemone toxin in the
S3-S4 extracellular loop in domain IV of the Na channel  subunit. J Biol Chem 271:15950–15962.
7. Cestèle S, Qu Y, Rogers JC, Rochat H, Scheuer T, and Catterall, WA (1998) Voltage sensor-trapping: enhanced activation of sodium channels by -scorpion toxin bound
to the S3-S4 loop in domain II. Neuron 21:919–931.
8. Westenbroek RE, Merrick DK, and Catterall WA (1989) Differential subcellular localization of the RI and RII Na
 channel subtypes in central neurons. Neuron
3:695–704.
9. Boiko T, Rasband MN, Levinson SR, Caldwell JH, Mandel G, Trimmer JS. and Matthews G. (2001)Compact myelin dictates the differential targeting of two sodium
channel isoforms in the same axon. Neuron 30:91–104.
10. Kaplan MR, Cho MH, Ullian EM, Isom LL, Levinson SR, and Barres BA (2001) Differential control of clustering of the sodium channels NaV1.2 and NaV1.6 at
developing CNS nodes of Ranvier. Neuron 30:105–119.
11. Sugawara T, Tsurubuchi Y, Agarwala KL, Ito M, Fukuma G, Mazaki-Miyazaki E, Nagafuji H, Noda M, Imoto K, Wada K, et al. (2001) A missense mutation of the
Na channel alpha II subunit gene NaV1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci USA 98:6384–6389.
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TABLE 4
NaV1.3 channels
Channel name NaV1.3
Description Voltage-gated sodium channel  subunit
Other names Brain type 3, rat 3, R-III
Molecular information Human: 1951aa, Q9NY46, XP0336775, NP008853, chr. 2q23-24, SCN3A
Rat: 1951aa, P08104, Y00766, NM_012647, chr. 3q24
Mouse: 2071aa, Q68V26, XM_355332, chr. 2
Associated subunits 1 and 3 modulate inactivation; time course of expression parallels 3
1,2
Functional assays Voltage-clamp, neurotoxin-activated ion flux, voltage-sensitive dyes
Current INa
Conductance Not established
Ion selectivity Na  K  Ca2
Activation Va  23 to 26 mV
3,4
Inactivation Vh  65 to 69 mV, h  0.8 to 1.5 ms at 10 mV
3,4
Activators Veratridine, batrachotoxin, aconitine, grayanotoxin, and related natural organic toxins; -scorpion
toxins
Gating modifiers -Scorpion toxins, sea anemone toxins, and -conotoxins, which all slow inactivation
Blockers Tetrodotoxin (EC50  4 nM),
1 saxitoxin; local anesthetic, antiepileptic, and antiarrhythmic drugs
Radioligands 3Hsaxitoxin, 3Hbatrachotoxin, 125Iscorpion toxins
Channel distribution Central neurones: primarily expressed in embryonic and early prenatal life; preferentially localized
in cell bodies in adult rat brain2,5,6; cardiac myocytes7
Physiological functions Action potential initiation and conduction; repetitive firing
Mutations and pathophysiology Not fully established; up-regulated in dorsal root ganglion neurons and dorsal horn neurons in
axotomy and other nerve injuries7,8; rapid recovery from inactivation contributes to
hyperexcitability following nerve injury10
Pharmacological significance Site of action of antiepileptic drugs; potential site of side effects of local anesthetics that enter the
general circulation or the cerebrospinal fluid
aa, amino acids; chr., chromosome.
1. Meadows LS, Chen YH, Powell AJ, Clare JJ, and Ragsdale DS (2002) Functional modulation of human NaV1.3 sodium channels expressed in mammalian cells, by
auxiliary 1, 2, and 3 subunits. Neuroscience 114:745–753.
2. Shah BS, Stevens EB, Pinnock RD, Dixon AK, and Lee K (2001) Developmental expression of the novel voltage-gated sodium channel subunit 3 in rat CNS. J Physiol
(Lond) 534:763–776.
3. Chen YH, Dale TJ, Romanos MA, Whitaker WR, Xie XM, and Clare JJ (2000) Cloning, distribution and functional analysis of the type III sodium channel from human
brain. Eur J Neurosci 12:4281–4289.
4. Cummins TR, Aglieco F, Renganathan M, Herzog RI, Dib-Hajj SD, and Waxman SG (2001) NaV1.3 sodium channels: rapid repriming and slow closed-state inactivation
display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons. J Neurosci 21:5952–5961.
5. Beckh S, Noda M, Lübbert H, and Numa S (1989) Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during
development. EMBO J 8:3611–3616.
6. Westenbroek RE, Noebels JL, and Catterall WA (1992) Elevated expression of type II Na channels in hypomyelinated axons of shiverer mouse brain. J Neurosci
12:2259–2267.
7. Maier SK, Westenbroek RE, Schenkman KA, Feigl EO, Scheuer T, and Catterall WA (2002) An unexpected role for brain-type sodium channels in coupling of cell surface
depolarization to contraction in the heart. Proc Natl Acad Sci USA 99:4073–4078.
8. Waxman SG, Kocsis JD, and Black JA (1994) Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is re-expressed
following axotomy. J Neurophysiol 72:466–472.
9. Hains BC, Saab CY, Klein JP, Craner MC, and Waxman SG (2004) Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after
peripheral nerve injury. J Neurosci 24:4832–4840.
10. Cummins TC and Waxman SG (1997) Down-regulation of tetrodotoxin-resistant sodium currents and up-regulation of a rapidly-repriming tetrodotoxin-sensitive
sodium current in spinal sensory neurons following nerve injury. J Neurosci 17:3503–3514.
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TABLE 5
NaV1.4 channels
Channel name Nav1.4
Description Voltage-gated sodium channel  subunit
Other names SkM1, 11
Molecular information Human: 1836aa, M81758, O60217, Q9H3L9,2,3 chr. 17q23-25,3 SCN4A
Rat: 1840aa, M26643, O706111
Mouse: 1841aa, AJ278787, Q9ER60,4 chr. 1164,5 Scn4A
Associated subunits 1
Functional assays Voltage-clamp, neurotoxin-activated ion flux, voltage-sensitive dyes
Current INa
Conductance 24.9pS human6
19.8pS rat7
Ion selectivity Na  K  Rb  Cs (channels reconstituted from rat skeletal muscle sarcolemma)8
Activation Va  30 mV (rat  subunit in Xenopus oocytes)
9
Va  26 mV (human  subunit in CHO cells)
10
Inactivation Vh  50.1 mV, h  0.8 and 	8 ms at 30 mV, h  	0.3 and 	3.5 ms at 10 mV (human 
subunit in Xenopus oocytes with 200-ms depolarizations using macropatch voltage-clamp)6
Vh  56 mV, h  1.1 ms at 20 mV (human  subunit in CHO cells with 500-ms
depolarizations)10
Activators Protein: -scorpion toxins11
Alkaloids: veratridine,12 batrachotoxin,12 grayanotoxin13
Gating Modifiers -Scorpion toxins and sea anemone toxins, which all slow inactivation14
Blockers Selective: -conotoxin GIIIA (EC50  19–54 nM in rat,
15,16 1.2 M in human6), -conotoxin PIIIA
(EC50  41 nM in rat
16)
Nonselective: tetrodotoxin (EC50  5 nM in rat,
1 25 nM in human6), saxitoxin (EC50  4.1 nM in
rat17)
Drugs: local anesthetic, antiepileptic, and antiarrhythmic drugs (lidocaine EC50  2128 M in
resting state at 130 mV in rat  subunit, 176 M in rat 1 subunits, 4.4 M for inactivated
state in rat  subunit, 0.9 M in rat 1 subunits
18; mexiletine EC50  431 M in resting state at
120 mV in rat 1 subunits, 68 M for inactivated state in rat 1 subunits
19)
Radioligands 125I scorpion toxin, 3Hbatrachotoxin, 3Hsaxitoxin, 3Htetrodotoxin
Channel distribution High levels in adult skeletal muscle and low levels in neonatal skeletal muscle20
Physiological functions Action potential initiation and transmission in skeletal muscle
Mutations and pathophysiology Point mutations in many locations cause hyperkalemic periodic paralysis, paramyotonia congenita,
potassium-aggravated myotonias21
Pharmacological significance Target of local anesthetics used to treat myotonia
aa, amino acids; chr., chromosome; CHO, Chinese hamster ovary.
1. Trimmer JS, Cooperman SS, Tomiko SA, Zhou J, Crean SM, Boyle MB, Kallen RG, Sheng Z, Barchi RL, Sigworth FJ, et al. (1989) Primary structure and functional
expression of a mammalian skeletal muscle sodium channel. Neuron 3:33–49.
2. George AL Jr, Komisarof J, Kallen RG, and Barchi RL (1992) Primary structure of the adult human skeletal muscle voltage-dependent sodium channel. Ann Neurol
31:131–137.
3. Wang J, Rojas CV, Zhou J, Schwartz LS, Nicholas H, and Hoffman EP (1992) Sequence and genomic structure of the human adult skeletal muscle sodium channel alpha
subunit gene on 17q. Biochem Biophys Res Commun 182:794–801.
4. Zimmer T, Bollensdorff C, Haufe V, Birch-Hirschfeld E, and Benndorf K (2002) Mouse heart Na channels: primary structure and function of two isoforms and
alternatively splice variants. Am J Physiol Heart Circ Physiol 282:H1007–H1017.
5. Ambrose C, Cheng S, Fontaine B, Nadeau JH, MacDonald M, and Gusella JF (1992) The alpha-subunit of the skeletal muscle sodium channel is encoded proximal to
Tk-1 on mouse chromosome 11. Mamm Genome 3:151–155.
6. Chahine M, Bennett PB, George AL Jr, and Horn R (1994) Functional expression and properties of the human skeletal muscle sodium channel. Pflugers Arch Eur
J Physiol 427:136–142.
7. Zhou J, Potts JF, Trimmer JS, Agnew WS, and Sigworth FJ (1991) Multiple gating modes and the effect of modulating factors on the muI sodium channel. Neuron
7:775–785.
8. Tanaka JC, Eccleston JF, and Barchi RL (1983) Cation selectivity characteristics of the reconstituted voltage-dependent sodium channel purified from rat skeletal
muscle sarcolemma. J Biol Chem 258:7519–7526.
9. Cannon SC, McClatchey AI, and Gusella JF (1993) Modification of the Na current conducted by the rat skeletal muscle alpha subunit by co-expression with a human
brain beta subunit. Pflugers Arch Eur J Physiol 423:155–157.
10. Bennett ES (2004) Channel activation voltage alone is directly altered in an isoform-specific manner by Nav1.4 and Nav1.5 cytosplasmic linkers. J Membr Biol
197:155–168.
11. Marcotte P, Chen L-Q, Kallen RG, and Chahine M (1997) Effects of Tityus serrulatus scorpion toxin gamma on voltage-gated Na channels. Circ Res 80:363–369.
12. Wang S-Y andWang GK (1998) Point mutations in segment I-S6 render voltage-gated Na channels resistant to batrachotoxin. Proc Natl Acad Sci USA 95:2653–2658.
13. Kimura T, Yamaoka K, Kinoshita E, Maejima H, Yuki T, Yakehiro M, and Seyama I (2001) Novel site on sodium channel -subunit responsible for the differential
sensitivity of grayanotoxin in skeletal and cardiac muscle. Mol Pharmacol 60:865–872.
14. Chahine M, Plante E, and Kallen RG (1996) Sea anemone toxin (ATX II) modulation of heart and skeletal muscle sodium channel -subunits expressed in tsA201 cells.
J Membr Biol 152:39–48.
15. Chen L-Q, Chahine M, Kallen RG, and Horn R (1992) Chimeric study of sodium channels from rat skeletal and cardiac muscle. FEBS Lett 309:253–257.
16. Safo P, Rosenbaum T, Shcherbatko A, Choi D-Y, Han E, Toledo-Aral J, Olivera BM, Brehm P, and Mandel G (2000) Distinction among neuronal subtypes of
voltage-activated sodium channels by -conotoxin PIIIA. J Neurosci 20:76–80.
17. Penzotti JL, Lipkind G, Fozzard HA, and Dudley SC Jr (2001) Specific neosaxitoxin interactions with the Na channel outer vestibule determined by mutant cycle
analysis. Biophys J 80:698–706.
18. Makielski JC, Limberis J, Fan Z and Kyle JW (1999) Intrinsic lidocaine affinity for Na channels expressed in Xenopus oocytes dependes on  (hH1 vs. rSkM1) and
1 subunits. Cardiovasc Res 42:503–509.
19. Wang GK, Russell C, and Wang S-Y (2004) Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na channels. J Physiol (Lond)
554:621–633.
20. Trimmer JS, Cooperman SS, Agnew WS, and Mandel G (1990) Regulation of muscle sodium channel transcripts during development and in response to denervation.
Dev Biol 142:360–367.
21. Cannon SC (1997) From mutation to myotonia in sodium channel disorders. Neuromuscul Disord 7:241–249.
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TABLE 6
NaV1.5 channels
Channel name NaV1.5
Description Voltage-gated sodium channel  subunit
Other names h1, skm II, cardiac sodium channel
Molecular information Human: 2016aa, Q14524, M77235, NM_198056 chr. 2q24, SCN5a
Rat: 1951aa, P15389, A33996, NM_013125
Mouse: 2019aa, Q9JJV9, AJ271477, NP067510, chr. 2
Associated subunits 1, 2, 3, 4
Functional assays Voltage-clamp, neurotoxin-activated ion flux, voltage-sensitive dyes
Current INa
Conductance 19–22pS1
Ion selectivity Na  K Ca2
Activation Va  47 mV, 56 mV with F as the major anion in the intracellular solution
2,3
Va  27 mV with aspartate as the major anion in the intracellular solution
4
a  2.8 ms, 1.6 ms at Va
2,4
Inactivation Vh  84 mV, 100 mV with F as the major anion in the intracellular solution
2,3
Vh  61 mV with aspartate as the major anion in the intracellular solution, h  1 ms at 0 mV
4
Activators Veratridine, batrachotoxin, aconitine, and related natural organic toxins
Gating modifiers -Scorpion toxins, sea anemone toxins, and -conotoxins, which all slow inactivation (see
“Comments”)
Blockers Tetrodotoxin (TTX-insensitive, Kd  1–2 mM),
5 saxitoxin; local anesthetic, antiepileptic, and
antiarrhythmic drugs (EC50  16 mM for lidocaine block of inactivated channels
6)
Radioligands 3Hbatrachotoxin (Kd  25 nM in the presence of -scorpion toxin)
7,8
Channel distribution Cardiac myocytes,9 immature and denervated skeletal muscle,10 certain brain neurons11
Physiological functions Action potential initiation and conduction
Mutations and pathophysiology Point mutations and deletions cause long QT syndrome and idiopathic ventricular fibrillation due to
slow and incomplete inactivation of the cardiac sodium current and resulting prolongation of the
action potential12
Pharmacological significance Site of action of antiarrhythmic drugs; site of toxic side effects of local anesthetics that reach the
general circulation
Comments NaV1.5 has lower affinity for - and -scorpion toxins than neuronal sodium channels
13
aa, amino acids; chr., chromosome; TTX, tetrodotoxin.
1. Fozzard HA and Hanck, DA (1996) Structure and function of voltage-dependent sodium channels: Comparison of brain II and cardiac isoforms. Physiol Rev 76:887–926.
2. Sheets MF and Hanck DA (1999) Gating of skeletal and cardiac muscle sodium channels in mammalian cells. J Physiol 514:425–436.
3. Li RA, Ennis IL, Tomaselli GF, and Marban E (2002) Structural basis of differences in isoform-specific gating and lidocaine block between cardiac and skeletal muscle
sodium channels. Mol Pharmacol 61:136–141.
4. Mantegazza M, Yu FH, Catterall WA, and Scheuer T (2001) Role of the C-terminal domain in inactivation of brain and cardiac sodium channels. Proc Natl Acad Sci
USA 98:15348–15353.
5. Satin J, Kyle JW, Chen M, Bell P, Cribbs LL, Fozzard HA, and Rogart RB (1992) A mutant of TTX-resistant cardiac sodium channels with TTX-sensitive properties
Science 256:1202–1205.
6. Nuss HB, Tomaselli GF, and Marbán E (1995) Cardiac sodium channels (hH1) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (1)
channels. J Gen Physiol 106:1193–1209.
7. Sheldon RS, Cannon NJ, and Duff HJ (1986) Binding of 3Hbatrachotoxinin A benzoate to specific sites on rat cardiac sodium channels. Mol Pharmacol 30:617–623.
8. Taouis M, Sheldon RS, Hill RJ, and Duff HJ (1991) Cyclic AMP-dependent regulation of the number of 3Hbatrachotoxinin benzoate binding sites on rat cardiac
myocytes. J Biol Chem 266:10300–10304.
9. Rogart RB, Cribbs LL, Muglia LK, Kephart DD, and Kaiser MW (1989) Molecular cloning of a putative tetrodotoxin-resistant rat heart Na channel isoform. Proc Natl
Acad Sci USA 86:8170–8174.
10. Kallen RG, Sheng ZH, Yang J, Chen LQ, Rogart RB, and Barchi RL (1990) Primary structure and expression of a sodium channel characteristic of denervated and
immature rat skeletal muscle. Neuron 4:233–242.
11. Hartmann HA, Colom LV, Sutherland ML, and Noebels JL (1999) Selective localization of cardiac SCN5A sodium channels in limbic regions of rat brain. Nat Neurosci
2:593–595.
12. Keating MT and Sanguinetti MC (2001) Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104:569–580.
13. Rogers JC, Qu Y, Tanada TN, Scheuer T, and Catterall WA (1996) Molecular determinants of high affinity binding of -scorpion toxin and sea anemone toxin in the
S3-S4 extracellular loop in domain IV of the Na channel  subunit. J Biol Chem 271:15950–15962.
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TABLE 7
NaV1.6 channels
Channel name Nav1.6
Description Voltage-gated sodium channel  subunit
Other names NaCh6,1 PN4,2 CerIII3
Molecular information Human: 1980aa, O95788, Q9NYX2, A9UQD0, AF050736, AF225988, chr. 12q13,4 SCN8A
Rat: 1976aa, L39018, AF049239, AF0492401,2
Mouse: 1976aa, Q60858, AF050736, AF225988,5,6 chr. 1564,5
Scn8A
Associated subunits 1, 2
Functional assays Voltage-clamp, neurotoxin-activated ion flux, voltage-sensitive dyes
Current INa
Conductance Not established
Ion selectivity Na
Activation Va  8.8 mV (mouse  subunit in Xenopus oocytes with cut-open oocyte voltage-clamp)
6
Va  17 mV (mouse  subunit with 1 and 2 in Xenopus oocytes with cut-open oocyte voltage-
clamp)6
Va  26 mV, a  0.51 ms and 4.65 ms at 10 mV (mouse  subunit with inactivation removed
and 1 and 2 in Xenopus oocytes with cut-open oocyte voltage-clamp)
7
Va  37.7 mV, a not determined (rat  subunit in Xenopus oocytes with macropatch voltage-
clamp)2,7
Inactivation Vh  55 mV, h  1.2 and 2.1 ms at 10 mV, h  0.98 and 11.6 ms at 10 mV (mouse  subunit
in Xenopus oocytes with 500-ms depolarizations using two-electrode voltage-clamp)6
Vh  51 mV, h  7.1 ms at 20 mV, h  0.78 and 8.1 ms at 10 mV (mouse  subunit with 1
and 2 in Xenopus oocytes with 500-ms depolarizations using two-electrode voltage-clamp)
6
Vh 97.6 mV, h  1 ms at 30 mV (rat  subunit in Xenopus oocytes with 5-s depolarizations
using macropatch voltage-clamp)2
Activators Veratridine, batrachotoxin (based on studies with rat brain sodium channels)
Gating modifiers -Scorpion toxins and sea anemone toxins, which all slow inactivation8
Blockers Nonselective: tetrodotoxin (EC50  1 nM in rat,
2 6 nM in mouse6), saxitoxin; local anesthetic,
antiepileptic, and antiarrhythmic drugs
Radioligands 125I-scorpion toxin, 3Hbatrachotoxin, 3Hsaxitoxin
3Htetrodotoxin (based on studies with rat brain sodium channels)
Channel distribution Somatodendritic distribution in output neurons of the cerebellum, cerebral cortex, and hippocampus;
Purkinje cells in the cerebellar granule cell layer; brainstem and spinal cord, astrocytes, and
Schwann cells; DRG; nodes of Ranvier of sensory and motor axons in the PNS; nodes of Ranvier
in the CNS1,9–11
Physiological functions Action potential initiation and transmission in central neurons and their myelinated axons; partially
responsible for the resurgent and persistent current in cerebellar Purkinje cells12
Mutations and pathophysiology Point mutation in II S4-S5 causes cerebellar ataxia in jolting mice13; gene disruption causes motor
endplate disease in mice5
Pharmacological significance Potential target for antiepileptic and analgesic drugs
aa, amino acids; chr., chromosome; DRG, dorsal root ganglion; PNS, peripheral nerve system; CNS, central nervous system.
1. Schaller KL, Krzemien DM, Yarowsky PJ, Krueger BK, and Caldwell JH (1995) A novel, abundant sodium channel expressed in neurons and glia. J Neurosci
15:3231–3242.
2. Dietrich PS, McGivern JG, Delgado SG, Koch BD, Eglen RM, Hunter JC, and Sangameswaran L (1998) Functional analysis of a voltage-gated sodium channel and its
splice variant from rat dorsal root ganglion. J Neurochem 70:2262–2272.
3. Vega-Saenz de Miera E, Rudy B, Sugimori M, and Llinas R (1997) Molecular characterization of the sodium channel subunits expressed in mammalian cerebellar
Purkinje cells. Proc Natl Acad Sci USA 94:7059–7064.
4. Plummer NW, Galt J, Jones JM, Burgess DL, Sprunger LK, Kohrman DC, and Meisler MH (1998) Exon organization, coding sequence, physical mapping, and
polymorphic intragenic markers for the human neuronal sodium channel gene SCN8A. Genomics 54:287–296.
5. Burgess DL, Kohrman DC, Galt J, Plummer NW, Jones JM, Spear B, and Meisler MH (1995) Mutation of a new sodium channel gene, Scn8a, in the mouse mutant
‘motor endplate disease’. Nat Genet 10:461–465.
6. Smith MR, Smith RD, Plummer NW, Meisler MH, and Goldin AL (1998) Functional analysis of the mouse Scn8a sodium channel. J Neurosci 18:6093–6102.
7. Zhou W and Goldin AL (2004) Use-dependent potentiation of the Nav1.6 sodium channel. Biophys J 87:3862–3872.
8. Oliveira JS, Redaelli E, Zaharenko AJ, Cassulini RR, Konno K, Pimenta DC, Freitas JC, Clare JJ, and Wanke E (2004) Binding specificity of sea anemone toxins to
Nav 1.1–1.6 sodium channels. Unexpected contributions from differences in the IV/S3-S4 outer loop. J Biol Chem 279:33323–33335.
9. Whitaker W, Faull R, Waldvogel H, Plumpton C, Burbidge S, Emson P, and Clare J (1999) Localization of the type VI voltage-gated sodium channel protein in human
CNS. Neuroreport 10:3703–3709.
10. Tzoumaka E, Tischler AC, Sangameswaran L, Eglen RM, Hunter JC, and Novakovic SD (2000) Differential distribution of the tetrodotoxin-sensitive rPN4/NaCh6/
Scn8a sodium channel in the nervous system. J Neurosci Res 60:37–44.
11. Caldwell JH, Schaller KL, Lasher RS, Peles E, and Levinson SR (2000) Sodium channel Nav1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc Natl
Acad Sci USA 97:5616–5620.
12. Raman IM, Sprunger LK, Meisler MH, and Bean BP (1997) Altered subthreshold sodium currents and disrupted firing patterns in Purkinje neurons of Scn8amutant
mice. Neuron 19:881–891.
13. Kohrman DC, Smith MR, Goldin AL, Harris J, and Meisler MH (1996) A missense mutation in the sodium channel Scn8a is responsible for cerebellar ataxia in the
mouse mutant jolting. J Neurosci 16:5993–5999.
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TABLE 8
NaV1.7 channels
Channel name Nav1.7
Description Voltage-gated sodium channel  subunit
Other names PN1,1,2 hNE-Na,3 Nas4
Molecular information Human: 1977aa, X82835,3 chr. 2q24, SCN9A
Rat: 1984aa, AF000368, U795681,2
Mouse: chr. 236,5,6 Scn9A
Associated subunits 1, 2
Functional assays Voltage-clamp, neurotoxin-activated ion flux, voltage-sensitive dyes
Current INa
Conductance 19.5pS (for TTX-sensitive current in DRG neurons)7
Ion selectivity Na
Activation Va  31 mV (rat  subunit in Xenopus oocytes with macropatch)
2
Va  45 mV (TTX-sensitive current in DRG neurons)
7
Inactivation Vh  78 mV, h  0.46 and 20 ms at 30 mV, h  0.1 and 1.8 ms at 10 mV (rat  subunit in
Xenopus oocytes with 10-s depolarizations using two-electrode voltage-clamp)2
Vh  60.5 mV (human  subunit in HEK cells with 2-s depolarizations using whole-cell patch
clamp)3
Vh  39.6 mV (human  subunit with 1 subunit in HEK cells with 2-s depolarizations using
whole-cell patch clamp)3
Vh  65 mV (TTX-sensitive current in DRG neurons with 50-ms to 1-s depolarizations using
whole-cell patch clamp)7
Activators Veratridine, batrachotoxin (based on studies with rat brain sodium channels)
Gating modifiers -Scorpion toxins and sea anemone toxins, which probably slow inactivation based on studies with
peripheral nerves and Nav1.2
8,9
Blockers Nonselective: tetrodotoxin (EC50  4 nM in rat,
2 25 nM in human3), saxitoxin; local anesthetic,
antiepileptic, and antiarrhythmic drugs (lidocaine EC50  450 M in resting state at 100 mV
10)
Radioligands 125I-scorpion toxin, 3Hbatrachotoxin, 3Hsaxitoxin 3Htetrodotoxin (based on studies with rat
brain sodium channels)
Channel distribution All types of DRG neurons, sympathetic neurons, Schwann cells, and neuroendocrine cells2,3,11
Physiological functions Action potential initiation and transmission in peripheral neurons; slow closed-state inactivation
facilitates response to slow, small depolarizations12
Mutations and pathophysiology Mutations (I848T and I858H), observed in inherited erythromelalgia, negatively shift activation,
slow deactivation, and enhance response to small depolarizations13,14
Pharmacological significance Probable target of local anesthetics in the peripheral nervous system
aa, amino acids; chr., chromosome; TTX, tetrodotoxin; DRG, dorsal root ganglion; HEK, human embryonic kidney.
1. Toledo-Aral JJ, Moss BL, He Z-J, Koszowski G, Whisenand T, Levinson SR, Wolf JJ, Silos-Santiago I, Halegoua S, and Mandel G (1997) Identification of PN1, a
predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci USA 94:1527–1532.
2. Sangameswaran L, Fish LM, Koch BD, Rabert DK, Delgado SG, Ilnikca M, Jakeman LB, Novakovic S, Wong K, Sze P, et al. (1997) A novel tetrodotoxin-sensitive,
voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem 272:14805–14809.
3. Klugbauer N, Lacinova L, Flockerzi V, and Hofmann F (1995) Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated
sodium channel family from human neuroendocrine cells. EMBO J 14:1084–1090.
4. Belcher SM, Zerillo CA, Levenson R, Ritchie JM, and Howe JR (1995) Cloning of a sodium channel  subunit from rabbit Schwann cells. Proc Natl Acad Sci USA
92:11034–11038.
5. Beckers M-C, Ernst E, Belcher S, Howe J, Levenson R, and Gros P (1996) A new sodium channel -subunit gene (Scn9a) from Schwann cells maps to the Scn1a, Scn2a,
Scn3a cluster of mouse chromosome 2. Genomics 36:202–205.
6. Kozak CA and Sangameswaran L (1996) Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. Mamm Genome 7:787–792.
7. Rush AM, Bräu ME, Elliott AA, and Elliott JR (1998) Electrophysiological properties of sodium current subtypes in small cells from adult rat dorsal root ganglia.
J Physiol (Lond) 511:771–789.
8. Cestèle S, Qu Y, Rogers JC, Rochat H, Scheuer T, and Catterall WA (1998) Voltage sensor-trapping: enhanced activation of sodium channels by -scorpion toxin bound
to the S3-S4 loop in domain II. Neuron 21:919–931.
9. Rogers JC, Qu Y, Tanada TN, Scheuer T, and Catterall WA (1996) Molecular determinants of high affinity binding of -scorpion toxin and sea anemone toxin in the
S3-S4 extracellular loop in domain IV of the Na channel  subunit. J Biol Chem 271:15950–15962.
10. Chevrier P, Vijayaragavan K, and Chahine M (2004) Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine.
Br J Pharmacol 142:576–584.
11. Felts PA, Yokoyama S, Dib-Hajj S, Black JA, and Waxman SG (1997) Sodium channel -subunit mRNAs I, II, III, NaG, Na6 and hNE (PN1): different expression
patterns in developing rat nervous system. Mol Brain Res 45:71–82.
12. Cummins TR, Howe JR, and Waxman SG (1998) Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium
channel. J Neurosci 18:9607–9617.
13. Yang Y, Wang Y, Li S, Xu Z, Li H, Ma I, Fan J, Bu D, Liu B, Fan Z, et al. (2004) Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with
primary erythermalgia. J Med Genetics 41:171–174.
14. Cummins TR, Dib-Hajj SD, and Waxman SG (2004) Electrophysiological properties of mutant NaV1.7 sodium channels in a painful inherited neuropathy. J Neurosci
24:8232–8236.
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TABLE 9
NaV1.8 channels
Channel name NaV1.8
Description Voltage-gated sodium channel  subunit
Other names SNS, PN3
Molecular information Human: 1957aa, Q9Y5Y9, NM_006514, chr. 3P21-3P24, SCN10A
Rat: Q63554, Q62968, NM_017247, U53833
Mouse: P70276, NM_009134, chr. 9
Associated subunits Not established
Functional assays Voltage-clamp, voltage-sensitive dyes
Current ITTX-Rslow
Conductance Not established
Ion selectivity Na
Activation Threshold  40 to 30 mV (rat DRG)1,2
Va  16 to 21 mV (rat DRG)
1,2
a  0.54 ms at 20 mV, 0.36 ms at 10 mV
Inactivation Vh  	30 mV (rat DRG), h  13.5 ms at 20mV, 5.6 ms at 10 mV
Activators Not established
Gating modifiers Not established
Blockers Tetrodotoxin (TTX-resistant, EC50  60 mM), lidocaine (and probably other local anesthetics) at
high concentrations3
Radioligands None
Channel distribution Small and medium-sized DRG neurones and their axons4
Physiological functions Contributes substantially to the inward current underlying the action potential in DRG neurones5;
adds a slowly inactivating sodium current component
Mutations and pathophysiology Point mutation of Ser356 to an aromatic residue removes TTX resistance6; NaV1.8-null mice exhibit
reduced pain responses to noxious mechanical stimuli, delayed development of inflammatory
hyperalgesia, and small deficits in noxious thermoreception,7suggesting a role of Nav1.8 in
nociception and in chronic pain; Nav1.8 is up-regulated in some models of inflammatory pain
8
Pharmacological significance Potential target for analgesic drugs
Comments Rapid recovery from inactivation is conferred by a three-amino acid insert in IVS3–S49; expression
is regulated by NGF and GDNF10; insertion of functional Nav1.8 channels in cell membrane is
facilitated by annexin II/p1111
aa, amino acids; chr., chromosome; TTX, tetrodotoxin; DRG, dorsal root ganglion; NGF, nerve growth factor; GDNF, glial cell-derived growth factor.
1. Cummins TR and Waxman SG (1997) Down-regulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium
current in small spinal sensory neurons after nerve injury. J Neurosci 17:3503–3514.
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TABLE 10
NaV1.9 channels
Channel name NaV1.9
Description Voltage-gated sodium channel  subunit
Other names NaN, SNS-2
Molecular information human: 1792aa, Q9UHE0, AF188679, chr. 3p21-3p24, SCN11A
Rat: 1765aa, 088457, NM_019265, AJ237852,
Mouse: 1765aa, Q9R053, NM_011887, chr. 9
Associated subunits Not established
Functional assays Voltage clamp
Current INaTTX-RP
Conductance Not established
Ion selectivity Na
Activation Threshold  70 to 60 mV (rat DRG), 80mV (human)
Va  47 to 54 mV (rat DRG)
1,2,3; a  2.93 ms at 60 mV, 4.1 ms at 50 mV, 3.5 ms at 20
mV, and 2.5 ms at 10 mV3
Inactivation Vh  44 to 54 mV
1,3; h  843 ms at 60 mV, 460 ms at 50 mV, 43 ms at 20 mV, and 16 ms
at 10 mV3
Activators Not established
Gating modifiers Not established
Blockers Tetrodotoxin (TTX-resistant, EC50  40 mM)
Radioligands None
Channel distribution c-type DRG neurones, trigeminal neurones and their axons; preferentially expressed in nociceptive
DRG neurons4
Physiological functions Contributes a depolarizing influence to resting potential, amplifies slow subthreshold
depolarizations1,3 and modulates excitability of cell membrane5
Mutations and pathophysiology Preferential expression in c-type dorsal root ganglion neurons suggests a role in nociception
Pharmacological significance Potential target for analgesic drugs
Comments Expression is regulated by GDNF6; NaV1.9 current is increased by inflammatory mediators such as
PGE2
7
aa, amino acids; chr., chromosome; DRG, dorsal root ganglion; TTX, tetrodotoxin; GDNF, glial cell-derived growth factor; PG, prostaglandin.
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